Loading clinical trials...
Loading clinical trials...
Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
Conditions
Interventions
ABVD
BEACOPP
+1 more
Locations
55
United States
Naval Medical Center -San Diego
San Diego, California, United States
Saint Helena Hospital
St. Helena, California, United States
Beebe Medical Center
Lewes, Delaware, United States
Delaware Clinical and Laboratory Physicians PA
Newark, Delaware, United States
Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, United States
Start Date
September 1, 2010
Primary Completion Date
September 30, 2020
Completion Date
September 29, 2021
Last Updated
December 1, 2021
NCT07545603
NCT07137494
NCT05969860
NCT07218341
NCT05475925
NCT06870760
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions